MIOT
ONC

Massachusetts Institute of Technology’s BeOne Medicines Ltd ONC Stock Holding History

Massachusetts Institute of Technology’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,754
Closed -$337K – 6
2019
Q3 		$337K Buy
+2,754
New +$366K 0.36% 5
2019
Q1 		– Sell
-7,669
Closed -$1.08M – 6
2018
Q4 		$1.08M Buy
+7,669
New +$1.02M 0.92% 4

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Massachusetts Institute of Technology's ONC Position: Q4 2019 in Review

Massachusetts Institute of Technology sold out of BeOne Medicines Ltd (ONC) in Q4 2019, closing a stake of 2,754 shares — an estimated $337K sold.

Massachusetts Institute of Technology first reported a position in ONC in Q4 2018 and held it in 2 quarters. The position peaked at $1.08M in Q4 2018. 221 funds tracked by Wall St. Rank hold ONC as of Q4 2019.

  • Massachusetts Institute of Technology reported no remaining BeOne Medicines Ltd position as of Q4 2019 after selling out during the quarter.
  • Massachusetts Institute of Technology sold 2,754 BeOne Medicines Ltd shares in Q4 2019, an estimated $337K.
  • Massachusetts Institute of Technology first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 2 quarters.
  • Massachusetts Institute of Technology's BeOne Medicines Ltd position peaked at $1.08M in Q4 2018.
  • 221 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2019.

Based on Massachusetts Institute of Technology's 13F filing for Q4 2019, filed 13 Feb 2020.